Podcast
Questions and Answers
Which of the following mechanisms contributes to the pathogenesis of Crohn's disease?
Which of the following mechanisms contributes to the pathogenesis of Crohn's disease?
- Innate immune response activation due to increased NOD2 function.
- Th2 T-cell mediated activation of eosinophils.
- Th1 T-cell and cytokine mediated chronic inflammation. (correct)
- Decreased adaptive immune response due to NOD2 mutation.
What is the role of the NOD2 receptor in the context of Crohn's disease pathophysiology?
What is the role of the NOD2 receptor in the context of Crohn's disease pathophysiology?
- It directly activates the adaptive immune response, leading to increased inflammation.
- It inhibits the release of pro-inflammatory cytokines, suppressing the inflammatory response.
- It binds to lipopolysaccharide (LPS), leading to NF-kB pathway activation. (correct)
- It triggers the formation of caseating granulomas in the affected tissues.
Which of the following is a characteristic distribution pattern of lesions in Crohn's disease?
Which of the following is a characteristic distribution pattern of lesions in Crohn's disease?
- Patchy inflammation known as 'skip' lesions occurring anywhere from the mouth to the anus. (correct)
- Continuous inflammation extending from the rectum proximally.
- Confined inflammation primarily affecting the stomach and duodenum.
- Uniform inflammation of the colon, sparing the terminal ileum.
Which of the following complications arises directly from transmural inflammation in Crohn's disease?
Which of the following complications arises directly from transmural inflammation in Crohn's disease?
What are the expected long-term consequences of chronic inflammation in Crohn's disease?
What are the expected long-term consequences of chronic inflammation in Crohn's disease?
Which of the following factors is known to increase the risk of developing Crohn's disease?
Which of the following factors is known to increase the risk of developing Crohn's disease?
A patient with Crohn's disease presents with RLQ pain and chronic diarrhea. What other symptom is closely associated with malabsorption in Crohn's disease?
A patient with Crohn's disease presents with RLQ pain and chronic diarrhea. What other symptom is closely associated with malabsorption in Crohn's disease?
Which of the following extraintestinal manifestations is commonly associated with Crohn's disease?
Which of the following extraintestinal manifestations is commonly associated with Crohn's disease?
What hepatobiliary complication are patients with Crohn's disease at an increased risk of developing?
What hepatobiliary complication are patients with Crohn's disease at an increased risk of developing?
Which of the following histological findings is characteristic of Crohn's disease?
Which of the following histological findings is characteristic of Crohn's disease?
Which of the following serological markers is most specific for Crohn's disease?
Which of the following serological markers is most specific for Crohn's disease?
What would be a key finding on imaging, particularly on X-ray, suggestive of Crohn's disease?
What would be a key finding on imaging, particularly on X-ray, suggestive of Crohn's disease?
What endoscopic finding is characterized by the appearance of normal mucosa surrounded by areas of inflammation?
What endoscopic finding is characterized by the appearance of normal mucosa surrounded by areas of inflammation?
Which class of medications is often the first-line treatment to induce remission in Crohn's disease?
Which class of medications is often the first-line treatment to induce remission in Crohn's disease?
Which of the following drug classes directly targets TNF-α to reduce inflammation in Crohn's disease?
Which of the following drug classes directly targets TNF-α to reduce inflammation in Crohn's disease?
What is a potential long-term complication following surgical resection (colectomy/ileectomy) for Crohn's disease?
What is a potential long-term complication following surgical resection (colectomy/ileectomy) for Crohn's disease?
Which of the following statements best describes the mechanism of action of 5-ASA preparations like mesalamine and sulfasalazine in managing Crohn's disease?
Which of the following statements best describes the mechanism of action of 5-ASA preparations like mesalamine and sulfasalazine in managing Crohn's disease?
What is the primary mechanism by which immunosuppressors like azathioprine and 6-mercaptopurine help manage Crohn's disease?
What is the primary mechanism by which immunosuppressors like azathioprine and 6-mercaptopurine help manage Crohn's disease?
What is the significance of elevated fecal calprotectin and lactoferrin levels in the context of Crohn's disease diagnostics?
What is the significance of elevated fecal calprotectin and lactoferrin levels in the context of Crohn's disease diagnostics?
A patient with Crohn's disease has developed an enteroenteric fistula. What does this complication involve?
A patient with Crohn's disease has developed an enteroenteric fistula. What does this complication involve?
Flashcards
Crohn's Disease Pathophysiology
Crohn's Disease Pathophysiology
Th1 T-cell and cytokine mediated chronic inflammation. Mutation in NOD2 leads to decreased innate immunity and increased adaptive immunity.
NOD2 Receptor Role
NOD2 Receptor Role
Receptor that binds lipopolysaccharide (LPS), activating the NF-kB pathway. Mutation leads to increased adaptive immune response in Crohn's.
"Skip" Lesions
"Skip" Lesions
Discontinuous areas of inflammation occurring anywhere from mouth to anus, commonly in the terminal ileum.
Fibrosis and Wall Thickening in Crohn's
Fibrosis and Wall Thickening in Crohn's
Signup and view all the flashcards
Transmural Inflammation
Transmural Inflammation
Signup and view all the flashcards
Crohn's Disease Presentation
Crohn's Disease Presentation
Signup and view all the flashcards
Fistulas in Crohn's Disease
Fistulas in Crohn's Disease
Signup and view all the flashcards
Extraintestinal Manifestations of Crohn's
Extraintestinal Manifestations of Crohn's
Signup and view all the flashcards
Histological Findings of Crohn's
Histological Findings of Crohn's
Signup and view all the flashcards
Positive ASCA
Positive ASCA
Signup and view all the flashcards
Lab Findings in Crohn's
Lab Findings in Crohn's
Signup and view all the flashcards
"String" Sign
"String" Sign
Signup and view all the flashcards
Medical Management of Crohn's
Medical Management of Crohn's
Signup and view all the flashcards
Surgical Management of Crohn's
Surgical Management of Crohn's
Signup and view all the flashcards
Study Notes
- Crohn's disease pathophysiology involves Th1 T-cell and cytokine-mediated chronic inflammation.
- A mutation in NOD2 leads to decreased innate immune response and increased adaptive immune response.
- The NOD2 receptor binds lipopolysaccharide (LPS), activating the NF-kB pathway.
- Skip lesions can occur anywhere from the mouth to the anus.
- The terminal ileum is the most commonly affected location.
- The rectum and stomach are less common sites for Crohn's disease.
- Chronic inflammation results in fibrosis and wall thickening, leading to a narrowed lumen.
- Transmural inflammation leads to epithelialization across the bowel wall, forming sinus tracts and fistulas.
- Smoking and HLA-B27 increase the risk of Crohn's disease.
Presentation
- Patients may experience RLQ pain, chronic diarrhea, and abscesses.
- Malabsorption of B12 and fat-soluble vitamins can occur.
- Fistulas can be enteroenteric, enterocutaneous, or enterovesical.
- Extraintestinal manifestations include uveitis, arthritis, erythema nodosum, and pyoderma gangrenosum.
- Other presentations include perianal disease, gallstones, nephrolithiasis, and increased risk for colorectal cancer.
Diagnostics
- Histology reveals lymphoid aggregates and noncaseating granulomas.
- Anti-Saccharomyces cerevisiae antibodies (ASCA) are often positive.
- Elevated ESR, CRP, fecal calprotectin, and fecal lactoferrin are common.
- A "string" sign may be visible on X-ray.
- "Knife-like" fissures, creeping fat, and cobblestone mucosa can be observed.
Management
- Corticosteroids and TNF-⍺ inhibitors (Infliximab, adalimumab) can be used.
- 5-ASA preparations (Mesalamine, sulfasalazine) are treatment options.
- Immunosuppressors like Azathioprine/6-mercaptopurine might be prescribed.
- Colectomy or ileectomy may be necessary, potentially leading to short bowel syndrome.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.